8-K

Company

Viking Therapeutics, Inc.

Filed

August 2, 2019

Period of Report

August 1, 2019

Accession Number

0001564590-19-028063

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →